| |
LPV/r + TDF (n=72) |
LPV/r + 2 NRTIs (n=80) |
| MaleA |
63 (87.5%) |
61 (76.3%) |
| CaucasianA |
62 (86.1%) |
70 (88.6%) |
| Age, yearsB |
39.92 (10.0) |
40.44 (9.9) |
| Karnofsky score (100)A |
61 (84.7%) |
68 (85.0%) |
| CD4 cell count,/mm3B |
244.77 (123.7) |
200.74 (117) |
| CD4 cell count,/mm3C |
231 (2-580) |
199.5 (3-639) |
Subjects with CD4 cell count ≤
200/mm3A |
29 (40.3%) |
41 (51.3%) |
| HIV-1 RNA (log10)B |
4.81 (0.7) |
4.91 (0.7) |
Subjects with HIV-1 RNA
>100.000 copies/mLA |
35 (48.6%) |
41 (51.3%) |
| Duration of infection, monthsB |
49.2 (74.0) |
30.0 (54.7) |
Anumber (%)
Bmean (s.d.)
Cmedian (range) |